Ayala Healthcare Holdings Inc. (AC Health), a unit of Ayala Corp., is selling about 16 percent to Singapore-based ABC Impact in the Temasek Trust-backed investor’s first Philippine healthcare venture.

AC Health said Monday that proceeds, which it did not disclose, will fund the expansion of its hospitals, clinics, and pharmacies through organic growth and acquisitions. By 2027, it is targeting 10 hospitals, 300 clinics, and 1,150 pharmacies.

AsPac portfolio

The investment adds to ABC Impact’s healthcare portfolio in the Asia Pacific region, including Vietnam and India.

“This partnership creates valuable opportunities for knowledge exchange, technology transfer, and the adoption of global best practices, further enabling AC Health to raise the bar in care quality, patient safety, and operational efficiency as it moves toward world-class standards,” AC Health president and CEO Paolo Borromeo said.

Meanwhile, ABC Impact CEO David Heng said they are leveraging their regional experience to help AC Health strengthen systems and reach more communities.

Well-positioned

“We believe AC Health is well-positioned to deliver meaningful social outcomes alongside sustainable growth. Through our regional healthcare experience and impact lens, we aim to support AC Health’s efforts to strengthen systems and serve more communities across the Philippines,” he said.

BofA Securities advised AC Health on the deal, which is subject to closing conditions.

Last week, AC Health also partnered with Indonesia’s Dexa Group to widen access to affordable, quality medicines through its Generika and St. Joseph Drug stores, Healthway hospitals, and import arm IE Medica.